Patient Perceptions of Switching to a Generic Dry Powder Inhaler – Increased Understanding Through Journey Mapping

Sarah E Ray1 Center for Communication Science, RTI International, Research Triangle Park, NC, USACorrespondence[email protected]

https://orcid.org/0000-0002-7023-4326

Vanessa Boudewyns1 Center for Communication Science, RTI International, Research Triangle Park, NC, USA

Christine Davis1 Center for Communication Science, RTI International, Research Triangle Park, NC, USA

Janice P Tzeng1 Center for Communication Science, RTI International, Research Triangle Park, NC, USA

Ila Srivastava2 Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA

Oluwamurewa Oguntimein3 Office of Medication Error Prevention and Risk Management, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA

Denise S Conti4 Office of Safety and Clinical Evaluation, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA

Karen B Feibus2 Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA

https://orcid.org/0000-0001-5964-9048

show all

Patient Perceptions of Switching to a Generic Dry Powder Inhaler – Increased Understanding Through Journey Mapping

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Patient Perceptions of Switching to a Generic Dry Powder Inhaler – Increased Understanding Through Journey Mapping

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date